ELV Earnings

ELV reported its FY2025Q3 earnings on 2025-10-21, showcasing a revenue of 50.09B against an estimate of 49.49B, resulting in a 1.21% surprise. The EPS was 6.03, surpassing the expected 4.98 by 21.08%. The stock experienced a -1.22% price change on the earnings day and a -3.31% change over the next five days, reflecting market reactions to the results.

Following ELV's FY2025Q3 earnings announcement on 2025-10-21, the stock price moved by -1.22% on the day of the release. Over the subsequent five days, it saw a -3.31% change. Historically, ELV's stock price tends to shift by an average of 1.55% in the 10 days leading up to earnings and -2.34% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ELV's annual revenue to reach 50.71B, while the EPS is projected at 10.39. These estimates reflect recent revisions, with revenue estimates revised upward by 0.05% and EPS estimates revised downward by -0.23% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ELV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.05%, while EPS estimates moved revised downward by -0.23%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ELV's stock price typically moves by 1.55% in the 10 days before its earnings and -2.34% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 10.39 and revenue of 50.71B.

The earnings call presents several concerns: declining Medicaid margins, membership losses, and unclear management responses. Despite some positive aspects like Carelon growth and strategic repositioning, these are overshadowed by negative trends and uncertainties, particularly around Medicare and Medicaid. The Q&A revealed further risks and lack of clarity, which likely weigh on investor sentiment. Given these factors, along with the absence of strong positive catalysts, a negative stock price reaction is anticipated.